Literature DB >> 1391328

Histological assessment of the mouse uterus from birth to puberty for the appearance of LGL-1+ natural killer cells.

Y Kiso1, B A McBey, L Mason, B A Croy.   

Abstract

The appearance of natural killer (NK) cells during growth and maturation of the murine uterus was studied by immunohistochemistry, using the monoclonal antibody LGL-1. To determine the contributions of microorganisms in the environment and of T-cell and B-cell regulation to the establishment of a uterine NK cell population, uteri from barrier-raised, flora-defined, random-bred CD-1 mice and from genetically T-cell- and B-cell-deficient SCID mice (genotype C.B-17 scid/scid) were compared to uteri from conventionally raised CD-1 mice. Uteri were studied from birth to the ages at which these mice are normally paired for mating (7-10 wk). Absolute uterine weight and the ratio of uterine weight to body weight increased remarkably between 3 and 5 wk of age in each group of animals. Growth continued beyond Week 5 of age, and in all groups the ratio of uterine weight to body weight was similar at puberty, although both the flora-defined CD-1 and SCID mice were significantly smaller than conventionally reared mice. LGL-1+ cells could not be detected in any of the neonatal uteri examined. LGL-1+ cells were first detected at 2 wk of age in uteri from the conventional and flora-defined CD-1 mice. A significant increase in the number of LGL-1+ NK cells occurred in the CD-1 uterus between Weeks 2 and 3 of age and again between Weeks 5 and 7 of age. Environmental conditions did not alter the frequency of LGL-1+ cells between the two groups of CD-1 mice at any age studied.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391328     DOI: 10.1095/biolreprod47.2.227

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  8 in total

Review 1.  A review of trafficking and activation of uterine natural killer cells.

Authors:  Marianne J van den Heuvel; Xuemei Xie; Chandrakant Tayade; Crystal Peralta; Yuan Fang; Sean Leonard; Valdemar A Paffaro; Abdol K Sheikhi; Coral Murrant; Barbara Anne Croy
Journal:  Am J Reprod Immunol       Date:  2005-12       Impact factor: 3.886

2.  Anti-tumor effects of adenovirus containing human growth hormone sequences in a mouse model of human ovarian cancer.

Authors:  Yonglian Zhu; José B Fariña; Syrus Meshack; Ana Santoveña; Shilpa Patel; Alexis Oliva; Matias Llabrés; Michael E Hodsdon; Carmen J Booth; Priscilla S Dannies
Journal:  Endocrine       Date:  2010-04-20       Impact factor: 3.633

Review 3.  Natural killer cell-triggered vascular transformation: maternal care before birth?

Authors:  Jianhong Zhang; Zhilin Chen; Graeme N Smith; B Anne Croy
Journal:  Cell Mol Immunol       Date:  2010-08-16       Impact factor: 11.530

4.  Distribution patterns of immunocompetent cells in the pregnant mouse uteri carrying allogeneic mouse and xenogeneic vole embryos.

Authors:  Diah Tri Widayati; Yasushige Ohmori; Katsuhiro Fukuta
Journal:  J Anat       Date:  2004-07       Impact factor: 2.610

5.  Murine endometrial and decidual NK1.1+ natural killer cells display a B220+CD11c+ cell surface phenotype.

Authors:  Thomas V Mallidi; Laura E Craig; Suzanne R Schloemann; Joan K Riley
Journal:  Biol Reprod       Date:  2009-04-15       Impact factor: 4.285

Review 6.  Phenotype and functions of conventional and non-conventional NK cells.

Authors:  Timothy K Erick; Laurent Brossay
Journal:  Curr Opin Immunol       Date:  2015-12-17       Impact factor: 7.486

Review 7.  Cytokines: Important for implantation?

Authors:  Gérard Chaouat; Sylvie Dubanchet; Nathalie Ledée
Journal:  J Assist Reprod Genet       Date:  2007-11-28       Impact factor: 3.412

Review 8.  Ly49 receptors: innate and adaptive immune paradigms.

Authors:  Mir Munir A Rahim; Megan M Tu; Ahmad Bakur Mahmoud; Andrew Wight; Elias Abou-Samra; Patricia D A Lima; Andrew P Makrigiannis
Journal:  Front Immunol       Date:  2014-04-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.